{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:25:09Z","timestamp":1773332709922,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ygyno.2017.05.023","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T09:00:35Z","timestamp":1495530035000},"page":"273-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Subtypes of stage IV ovarian cancer; response to treatment and patterns of disease recurrence"],"prefix":"10.1016","volume":"146","author":[{"given":"Amy","family":"Jamieson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4239-0313","authenticated-orcid":false,"given":"Lois","family":"Eva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecile","family":"Bergzoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryony","family":"Simcock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2017.05.023_bb0005","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/S0020-7292(06)60033-7","article-title":"Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynaecological cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2017.05.023_bb0010","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ygyno.2016.06.013","article-title":"FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited","volume":"142","author":"Ataseven","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.05.023_bb0015","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ygyno.2013.09.024","article-title":"Preoperative 18F-FDG PET\/CT in the management of advanced epithelial ovarian cancer","volume":"13","author":"Fruscio","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.05.023_bb0020","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1245\/s10434-011-2100-x","article-title":"Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer","volume":"19","author":"Rauh-Hain","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2017.05.023_bb0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3802\/jgo.2015.26.2.87","article-title":"FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"26","author":"Prat","year":"2015","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.05.023_bb0030","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/IGC.0000000000000675","article-title":"Restaging and survival analysis of 4036 ovarian cancer patients according to the 2013 FIGO classification for ovarian, fallopian tube, and primary peritoneal cancer","volume":"26","author":"Rosendahl","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2017.05.023_bb0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ygyno.2016.05.021","article-title":"The revised 2014 FIGO staging system for epithelial ovarian cancer: is a subclassification into FIGO stage IVA and IVB justified?","volume":"142","author":"Ataseven","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.05.023_bb0040","first-page":"124","article-title":"Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification","volume":"58","author":"Paik","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.05.023_bb0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2013.07.093","article-title":"Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: is there a case for thoracic cytoreduction?","volume":"131","author":"Perri","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.05.023_bb0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2008.09.010","article-title":"Stage IV ovarian cancer: disease site-specific rationale for postoperative treatment","volume":"112","author":"Aletti","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.05.023_bb0055","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ygyno.2013.05.040","article-title":"Survival impact of complete cytoreduction to no gross residual disease for advanced stage ovarian cancer: a meta-analysis","volume":"130","author":"Chang","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.05.023_bb0060","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9378(94)70090-7","article-title":"The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma","volume":"170","author":"Hoskins","year":"1994","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.05.023_bb0065","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2012.09.013","article-title":"Neoadjuvant chemotherapy in advanced ovarian cancer: on what do we agree and disagree?","volume":"128","author":"Vergote","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.05.023_bb0070","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3802\/jgo.2015.26.4.336","article-title":"Role of aggressive surgical cytoreduction in advanced ovarian cancer","volume":"26","author":"Chang","year":"2015","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.05.023_bb0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/gyno.1996.4550","article-title":"Stage IV ovarian cancer: impact of surgical debulking","volume":"64","author":"Curtin","year":"1997","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.05.023_bb0080","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.1998.5145","article-title":"Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer","volume":"72","author":"Bristow","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.05.023_bb0085","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1245\/s10434-010-0964-9","article-title":"Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group)","volume":"17","author":"Wimberger","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2017.05.023_bb0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2007.13.1953","article-title":"Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a gynecologic oncology group study","volume":"26","author":"Winter","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2017.05.023_bb0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2015.12.007","article-title":"Prognostic impact of debulking surgery and residual tumour in patients with epithelial ovarian cancer FIGO stage IV","volume":"140","author":"Ataseven","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.05.023_bb0100","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1245\/s10434-015-5051-9","article-title":"What should we expect after a complete cytoreduction at the time of interval or primary debulking surgery in advanced ovarian cancer?","volume":"23","author":"Chiva","year":"2016","journal-title":"Ann. Surg. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581730879X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581730879X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T10:53:40Z","timestamp":1535799220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082581730879X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S009082581730879X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.05.023","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subtypes of stage IV ovarian cancer; response to treatment and patterns of disease recurrence","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}